This topic contains a solution. Click here to go to the answer

Author Question: Absorbance or fluorescent sensors are used with which of the following? a. Capnography c. In ... (Read 30 times)

rlane42

  • Hero Member
  • *****
  • Posts: 594
Absorbance or fluorescent sensors are used with which of the following?
 
  a. Capnography c. In vitro blood gas analysis
  b. Photoplethysmog-raphy d. In vivo blood gas analysis

Question 2

Which size of scalp vein needle should be used to draw arterial blood from an infant?
 
  a. 22 gauge c. 26 gauge
  b. 24 gauge d. 28 gauge



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

srodz

  • Sr. Member
  • ****
  • Posts: 333
Answer to Question 1

ANS: D
In vivo blood gas monitors use optical sensors that are generally categorized in terms of how they modify the initial optical signal; they are classified as either absorbance or fluorescent sensors. Absorbance sensors absorb a fraction of the incident light as it is transmitted down the fiber and through the microcuvette. The amount of light transmitted is proportional to the concentration of the analyte in question. Fluorescent sensors use dyes that fluoresce when they are struck by light in the UV or near-UV visible range. Light from the monitor is transmitted to the microcuvette containing the dye. The concentration of the analyte in question can be measured by determining the ratio of fluorescent light emitted to the original excitation light signal.

Answer to Question 2

ANS: C
For infants, a 25-gauge to 26-gauge scalp vein needle can be used to collect arterial samples.




rlane42

  • Member
  • Posts: 594
Reply 2 on: Jul 16, 2018
Excellent


kilada

  • Member
  • Posts: 311
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

Bacteria have been found alive in a lake buried one half mile under ice in Antarctica.

Did you know?

About 3% of all pregnant women will give birth to twins, which is an increase in rate of nearly 60% since the early 1980s.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

More than 150,000 Americans killed by cardiovascular disease are younger than the age of 65 years.

Did you know?

If all the neurons in the human body were lined up, they would stretch more than 600 miles.

For a complete list of videos, visit our video library